{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "31978062", "DateCompleted": {"Year": "2020", "Month": "04", "Day": "10"}, "DateRevised": {"Year": "2020", "Month": "04", "Day": "10"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "01", "Day": "24"}], "Language": ["eng"], "ELocationID": ["e0227533", "10.1371/journal.pone.0227533"], "Journal": {"ISSN": "1932-6203", "JournalIssue": {"Volume": "15", "Issue": "1", "PubDate": {"Year": "2020"}}, "Title": "PloS one", "ISOAbbreviation": "PLoS One"}, "ArticleTitle": "Selective transmission of some HIV-1 subtype C variants might depend on Envelope stimulating dendritic cells to secrete IL-10.", "Pagination": {"StartPage": "e0227533", "MedlinePgn": "e0227533"}, "Abstract": {"AbstractText": ["Envelope (Env) phenotype(s) that provide transmitted founders (TF) with a selective advantage during HIV-1 transmission would be the ideal target for preventative therapy. We generated Env clones from four individuals infected with a single virus and one participant infected with multiple variants at transmission and compared phenotype with matched Envs from chronic infection (CI). When we determined whether pseudovirus (PSV) of the five TF and thirteen matched CI Env clones differed in their ability to 1) enter TZM-bl cells, 2) bind DC-SIGN, and 3) trans-infect CD4+ cells there was no association between time post-infection and variation in Env phenotype. However, when we compared the ability of PSV to induce monocyte-derived dendritic cells (MDDCs) to secrete Interleukin-10 (IL-10), we found that only TF Envs from single variant transmission cases induced MDDCs to secrete either higher or similar levels of IL-10 as the CI clones. Furthermore, interaction between MDDC DC-SIGN and Env was required for secretion of IL-10. When variants were grouped according to time post-infection, TF PSV induced the release of higher levels of IL-10 than their CI counterparts although this relationship varied across MDDC donors. The selection of variants during transmission is therefore likely a complex event dependent on both virus and host genetics. Our findings suggest that, potentially due to overall variation in N-glycosylation across variants, nuanced differences in binding of TF Env to DC-SIGN might trigger alternative DC immune responses (IRs) in the female genital tract (FGT) that favour HIV-1 survival and facilitate transmission."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa."}, {"Identifier": [], "Affiliation": "Institute of Infectious Disease and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa."}, {"Identifier": [], "Affiliation": "Institute for Medical Research and Medicinal Plants studies (IMPM), Ministry of Scientific Research and Innovation (MINRESI), Yaounde, Cameroon."}], "LastName": "Lumngwena", "ForeName": "Evelyn Ngwa", "Initials": "EN"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Integrative Biomedical Sciences, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa."}], "LastName": "Abrahams", "ForeName": "Bianca", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "National Institute for Communicable Diseases, National Health Laboratory Services, Johannesburg, South Africa."}], "LastName": "Shuping", "ForeName": "Liliwe", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, Maryland, United States of America."}], "LastName": "Cicala", "ForeName": "Claudia", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, Maryland, United States of America."}], "LastName": "Arthos", "ForeName": "James", "Initials": "J"}, {"Identifier": ["0000-0001-9680-3884"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Integrative Biomedical Sciences, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa."}], "LastName": "Woodman", "ForeName": "Zenda", "Initials": "Z"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "PLoS One", "NlmUniqueID": "101285081", "ISSNLinking": "1932-6203"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Cell Adhesion Molecules"}, {"RegistryNumber": "0", "NameOfSubstance": "DC-specific ICAM-3 grabbing nonintegrin"}, {"RegistryNumber": "0", "NameOfSubstance": "Lectins, C-Type"}, {"RegistryNumber": "0", "NameOfSubstance": "Receptors, Cell Surface"}, {"RegistryNumber": "0", "NameOfSubstance": "Vaccines, DNA"}, {"RegistryNumber": "0", "NameOfSubstance": "env Gene Products, Human Immunodeficiency Virus"}, {"RegistryNumber": "130068-27-8", "NameOfSubstance": "Interleukin-10"}], "MeshHeadingList": [{"QualifierName": ["metabolism"], "DescriptorName": "Cell Adhesion Molecules"}, {"QualifierName": ["immunology", "metabolism", "virology"], "DescriptorName": "Dendritic Cells"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Genetic Variation"}, {"QualifierName": [], "DescriptorName": "Glycosylation"}, {"QualifierName": [], "DescriptorName": "HEK293 Cells"}, {"QualifierName": ["genetics", "immunology", "physiology"], "DescriptorName": "HIV-1"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["metabolism"], "DescriptorName": "Interleukin-10"}, {"QualifierName": ["metabolism"], "DescriptorName": "Lectins, C-Type"}, {"QualifierName": [], "DescriptorName": "Phenotype"}, {"QualifierName": ["metabolism"], "DescriptorName": "Receptors, Cell Surface"}, {"QualifierName": ["immunology"], "DescriptorName": "Vaccines, DNA"}, {"QualifierName": [], "DescriptorName": "Virus Internalization"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "env Gene Products, Human Immunodeficiency Virus"}], "CoiStatement": "The authors declare that there are no conflicts of interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Buchbinder S. The epidemiology of new HIV infections and interventions to limit HIV transmission. Top HIV Med. 2009;17: 37\u201343.", "ArticleIdList": ["19401606"]}, {"Citation": "Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, Kaewkungwal J, Chiu J, Paris R, et al. Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand. N Engl J Med. 2009;361: 2209\u20132220. 10.1056/NEJMoa0908492", "ArticleIdList": ["10.1056/NEJMoa0908492", "19843557"]}, {"Citation": "Howard CJ, Charleston B, Stephens SA, Sopp P, Hope JC. The role of dendritic cells in shaping the immune response. Anim Heal Res Rev. 2004;5: 191\u2013195. 10.1079/AHR200468", "ArticleIdList": ["10.1079/AHR200468", "15984324"]}, {"Citation": "Hu J, Gardner MB, Miller CJ. Simian immunodeficiency virus rapidly penetrates the cervicovaginal mucosa after intravaginal inoculation and infects intraepithelial dendritic cells. J Virol. 2000;74: 6087\u20136095. 10.1128/jvi.74.13.6087-6095.2000", "ArticleIdList": ["10.1128/jvi.74.13.6087-6095.2000", "PMC112107", "10846092"]}, {"Citation": "Wu L, KewalRamani VN. Dendritic-cell interactions with HIV: infection and viral dissemination. Nat Rev Immunol. 2006;6: 859\u201368. 10.1038/nri1960", "ArticleIdList": ["10.1038/nri1960", "PMC1796806", "17063186"]}, {"Citation": "Nasi A, Amu S, G\u00f6thlin M, Jansson M, Nagy N, Chiodi F, et al. Dendritic cell response to HIV-1 is controlled by differentiation programs in the cells and strain-specific properties of the virus. Front Immunol. 2017;8: 1\u201310. 10.3389/fimmu.2017.00001", "ArticleIdList": ["10.3389/fimmu.2017.00001", "PMC5346539", "28348557"]}, {"Citation": "Schmidt S V., Nino-Castro AC, Schultze JL. Regulatory dendritic cells: There is more than just immune activation. Front Immunol. 2012;3: 1\u201317. 10.3389/fimmu.2012.00001", "ArticleIdList": ["10.3389/fimmu.2012.00001", "PMC3432880", "22969767"]}, {"Citation": "McDonald D. Dendritic cells and HIV-1 trans-infection. Viruses. 2010;2: 1704\u20131717. 10.3390/v2081704", "ArticleIdList": ["10.3390/v2081704", "PMC3185725", "21994702"]}, {"Citation": "Shan M, Klasse PJ, Banerjee K, Dey AK, Iyer SPN, Dionisio R, et al. HIV-1 gp120 mannoses induce immunosuppressive responses from dendritic cells. PLoS Pathog. 2007;3: 1637\u20131650. 10.1371/journal.ppat.0030169", "ArticleIdList": ["10.1371/journal.ppat.0030169", "PMC2048530", "17983270"]}, {"Citation": "Levast B, Barblu L, Coutu M, Prevost J, Brassard N, Peres A, et al. HIV-1 gp120 envelope glycoprotein determinants for cytokine burst in human monocytes. PLoS One. 2017;12: 1\u201315.", "ArticleIdList": ["PMC5367833", "28346521"]}, {"Citation": "Perona-Wright G, Jenkins SJ, Crawford A, Gray D, Pearce EJ, MacDonald AS. Distinct sources and targets of IL-10 during dendritic cell-driven Th1 and Th2 responses in vivo. Eur J Immunol. 2006;36: 2367\u20132375. 10.1002/eji.200535722", "ArticleIdList": ["10.1002/eji.200535722", "16917957"]}, {"Citation": "He Q, Moore TT, Eko FO, Lyn D, Ananaba GA, Martin A, et al. Molecular basis for the potency of IL-10-deficient dendritic cells as a highly efficient APC system for activating Th1 response. J Immunol (Baltimore, Md 1950). 2005;174: 4860\u20134869. 174/8/4860 [pii]", "ArticleIdList": ["15814713"]}, {"Citation": "Popov A, Schultze JL. IDO-expressing regulatory dendritic cells in cancer and chronic infection. J Mol Med. 2008;86: 145\u2013160. 10.1007/s00109-007-0262-6", "ArticleIdList": ["10.1007/s00109-007-0262-6", "17876564"]}, {"Citation": "Chohan B, Lang D, Sagar M, Korber B, Lavreys L, Richardson B, et al. Selection for human immunodeficiency virus type 1 envelope glycosylation variants with shorter V1-V2 loop sequences occurs during transmission of certain genetic subtypes and may impact viral RNA levels. J Virol. 2005;79: 6528\u201331. 10.1128/JVI.79.10.6528-6531.2005", "ArticleIdList": ["10.1128/JVI.79.10.6528-6531.2005", "PMC1091724", "15858037"]}, {"Citation": "Derdeyn C a, Decker JM, Bibollet-Ruche F, Mokili JL, Muldoon M, Denham S a, et al. Envelope-constrained neutralization-sensitive HIV-1 after heterosexual transmission. Science. 2004;303: 2019\u201322. 10.1126/science.1093137", "ArticleIdList": ["10.1126/science.1093137", "15044802"]}, {"Citation": "Go EP, Hewawasam G, Liao H-X, Chen H, Ping L-H, Anderson JA, et al. Characterization of glycosylation profiles of HIV-1 transmitted/founder envelopes by mass spectrometry. [Internet]. Journal of virology. 2011. 10.1128/JVI.05053-11", "ArticleIdList": ["10.1128/JVI.05053-11", "PMC3147976", "21653661"]}, {"Citation": "Geijtenbeek TB, Kwon DS, Torensma R, van Vliet SJ, van Duijnhoven GC, Middel J, et al. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell. 2000;100: 587\u2013597. 10.1016/s0092-8674(00)80694-7", "ArticleIdList": ["10.1016/s0092-8674(00)80694-7", "10721995"]}, {"Citation": "Nawaz F, Cicala C, van Ryk D, Block KE, Jelicic K, McNally JP, et al. The genotype of early-transmitting hiv gp120s promotes \u03b14\u03b27-reactivity, revealing \u03b14\u03b27+/CD4+T cells as key targets in mucosal transmission. PLoS Pathog. 2011;7: e1001301 10.1371/journal.ppat.1001301", "ArticleIdList": ["10.1371/journal.ppat.1001301", "PMC3044691", "21383973"]}, {"Citation": "Cicala C, Martinelli E, McNally JP, Goode DJ, Gopaul R, Hiatt J, et al. The integrin alpha4beta7 forms a complex with cell-surface CD4 and defines a T-cell subset that is highly susceptible to infection by HIV-1. Proc Natl Acad Sci U S A. 2009;106: 20877\u201382. 10.1073/pnas.0911796106", "ArticleIdList": ["10.1073/pnas.0911796106", "PMC2780317", "19933330"]}, {"Citation": "Nabatov AA, Van Montfort T, Geijtenbeek TBH, Pollakis G, Paxton WA. Interaction of HIV-1 with dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin-expressing cells is influenced by gp120 envelope modifications associated with disease progression. FEBS J. 2006;273: 4944\u20134958. 10.1111/j.1742-4658.2006.05491.x", "ArticleIdList": ["10.1111/j.1742-4658.2006.05491.x", "17010165"]}, {"Citation": "Hong PW, Nguyen S, Young S, Su S V, Lee B. Identification of the Optimal DC-SIGN Binding Site on Human Immunodeficiency Virus Type 1 gp120. J Virol. 2007;81: 8325\u20138336. 10.1128/JVI.01765-06", "ArticleIdList": ["10.1128/JVI.01765-06", "PMC1951277", "17522223"]}, {"Citation": "Liao C-F, Wang S-F, Lin Y-T, Ho DD, Chen Y-MA. Identification of the DC-SIGN-interactive domains on the envelope glycoprotein of HIV-1 CRF07_BC. AIDS Res Hum Retroviruses. 2011;27: 831\u2013839. 10.1089/AID.2010.0215", "ArticleIdList": ["10.1089/AID.2010.0215", "21142800"]}, {"Citation": "Feinberg H, Castelli R, Drickamer K, Seeberger PH, Weis WI. Multiple modes of binding enhance the affinity of DC-SIGN for high mannose N-linked glycans found on viral glycoproteins. J Biol Chem. 2007;282: 4202\u20139. 10.1074/jbc.M609689200", "ArticleIdList": ["10.1074/jbc.M609689200", "PMC2277367", "17150970"]}, {"Citation": "Brooks DG, Lee AM, Elsaesser H, McGavern DB, Oldstone MBA. IL-10 blockade facilitates DNA vaccine-induced T cell responses and enhances clearance of persistent virus infection. J Exp Med. 2008;205: 533\u201341. 10.1084/jem.20071948", "ArticleIdList": ["10.1084/jem.20071948", "PMC2275377", "18332180"]}, {"Citation": "Abrahams M-R, Anderson JA, Giorgi EE, Seoighe C, Mlisana K, Ping L-H, et al. Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants. J Virol. 2009;83: 3556\u201367. 10.1128/JVI.02132-08", "ArticleIdList": ["10.1128/JVI.02132-08", "PMC2663249", "19193811"]}, {"Citation": "Wu L, Martin TD, Carrington M, KewalRamani VN. Raji B cells, misidentified as THP-1 cells, stimulate DC-SIGN-mediated HIV transmission. Virology. 2004;318: 17\u201323. 10.1016/j.virol.2003.09.028", "ArticleIdList": ["10.1016/j.virol.2003.09.028", "14972530"]}, {"Citation": "Montefiori DC. Evaluating Neutralizing Antibodies Against HIV, SIV, and SHIV in Luciferase Reporter Gene Assays. Curr Protoc Immunol. 2005;64: 11.1\u201312.11.17. 10.1002/0471142735.im1211s64", "ArticleIdList": ["10.1002/0471142735.im1211s64", "18432938"]}, {"Citation": "Wei X, Decker JM, Wang S, Hui H, Kappes JC, Wu X, et al.\nAntibody neutralization and escape by HIV-1. Nature. 2003;422: 307\u201312. Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2742164&tool=pmcentrez&rendertype=abstract\n10.1038/nature01470\n", "ArticleIdList": ["10.1038/nature01470", "12646921"]}, {"Citation": "Alexandre KB, Gray ES, Mufhandu H, Mcmahon JB, Chakauya E, Keefe BRO, et al. The lectins grif fi thsin, cyanovirin-N and scytovirin inhibit HIV-1 binding to the DC-SIGN receptor and transfer to CD4 + cells. Virology. Elsevier Inc.; 2012;423: 175\u2013186. 10.1016/j.virol.2011.12.001", "ArticleIdList": ["10.1016/j.virol.2011.12.001", "PMC3274779", "22209231"]}, {"Citation": "van Loggerenberg F, Mlisana K, Williamson C, Auld SC, Morris L, Gray CM, et al. Establishing a cohort at high risk of HIV infection in South Africa: Challenges and experiences of the CAPRISA 002 acute infection study. PLoS One. 2008;3: 1\u20138. 10.1371/journal.pone.0001954", "ArticleIdList": ["10.1371/journal.pone.0001954", "PMC2278382", "18414658"]}, {"Citation": "Kwon DS, Gregorio G, Bitton N, Hendrickson WA, Littman DR. DC-SIGN-mediated internalization of HIV is required for trans-enhancement of T cell infection. Immunity. 2002;16: 135\u2013144. 10.1016/s1074-7613(02)00259-5", "ArticleIdList": ["10.1016/s1074-7613(02)00259-5", "11825572"]}, {"Citation": "Pohlmann S, Baribaud F, Lee B, Leslie GJ, Sanchez MD, Hiebenthal-millow K, et al. DC-SIGN Interactions with Human Immunodeficiency Virus Type 1 and 2 and Simian Immunodeficiency Virus. J Virol. 2001;75: 4664\u20134672. 10.1128/JVI.75.10.4664-4672.2001", "ArticleIdList": ["10.1128/JVI.75.10.4664-4672.2001", "PMC114220", "11312337"]}, {"Citation": "Wu L, Martin TD, Han Y-C, Breun SKJ, KewalRamani VN. Trans-dominant cellular inhibition of DC-SIGN-mediated HIV-1 transmission. Retrovirology. 2004;1: 14 10.1186/1742-4690-1-14", "ArticleIdList": ["10.1186/1742-4690-1-14", "PMC446230", "15222882"]}, {"Citation": "Lumngwena EN, Shuping L, Bernitz N, Woodman Z. HIV \u2011 1 subtype C Envelope function becomes less sensitive to N \u2011 glycosylation deletion during disease progression. BMC Res Notes. BioMed Central; 2019; 1\u20136. 10.1186/s13104-018-4038-6", "ArticleIdList": ["10.1186/s13104-018-4038-6", "PMC6580609", "31208438"]}, {"Citation": "Anthony C, York T, Bekker V, Matten D, Selhorst P, Ferreria R-C, et al. Cooperation between Strain-Specific and Broadly Neutralizing Responses Limited Viral Escape and Prolonged the Exposure of the Broadly Neutralizing. J Virol. 2017;91: 1\u201317.", "ArticleIdList": ["PMC5571269", "28679760"]}, {"Citation": "Raska M, Takahashi K, Czernekova L, Zachova K, Hall S, Moldoveanu Z, et al. Glycosylation patterns of HIV-1 gp120 depend on the type of expressing cells and affect antibody recognition. J Biol Chem. 2010;285: 20860\u201320869. 10.1074/jbc.M109.085472", "ArticleIdList": ["10.1074/jbc.M109.085472", "PMC2898351", "20439465"]}, {"Citation": "Turville SG, Cameron PU, Handley A, Lin G, P\u00f6hlmann S, Doms RW, et al. Diversity of receptors binding HIV on dendritic cell subsets. Nat Immunol. 2002;3: 975\u201383. 10.1038/ni841", "ArticleIdList": ["10.1038/ni841", "12352970"]}, {"Citation": "Lambert AA, Gilbert C, Richard M, Beaulieu AD, Tremblay MJ. The C-type lectin surface receptor DCIR acts as a new attachment factor for HIV-1 in dendritic cells and contributes to trans- and cis-infection pathways. Blood. 2008;112: 1299\u20131307. 10.1182/blood-2008-01-136473", "ArticleIdList": ["10.1182/blood-2008-01-136473", "PMC2515113", "18541725"]}, {"Citation": "Checkley MA, Luttge BG, Freed EO. HIV-1 envelope glycoprotein biosynthesis, trafficking, and incorporation. J Mol Biol. Elsevier B.V.; 2011;410: 582\u2013608. 10.1016/j.jmb.2011.04.042", "ArticleIdList": ["10.1016/j.jmb.2011.04.042", "PMC3139147", "21762802"]}, {"Citation": "Sagar M, Laeyendecker O, Lee S, Gamiel J, Wawer MJ, Gray RH, et al. Selection of HIV variants with signature genotypic characteristics during heterosexual transmission. J Infect Dis. 2009;199: 580\u2013589. 10.1086/596557", "ArticleIdList": ["10.1086/596557", "PMC2755256", "19143562"]}, {"Citation": "Sagar M. HIV-1 Transmission Biology: Selection and Characteristics of Infecting Viruses. Society. 2010;02139: 289\u2013296. 10.1086/655656", "ArticleIdList": ["10.1086/655656", "PMC2946383", "20846035"]}, {"Citation": "Keele BF, Giorgi EE, Salazar-gonzalez JF, Decker JM, Pham KT, Salazar MG, et al. Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. 2008;105 10.1073/pnas.0802203105", "ArticleIdList": ["10.1073/pnas.0802203105", "PMC2387184", "18490657"]}, {"Citation": "Pollakis G, Kang S, Kliphuis A, Chalaby MIM, Goudsmit J, Paxton WA. N-Linked Glycosylation of the HIV Type-1 gp120 Envelope Glycoprotein as a Major Determinant of CCR5 and CXCR4 Coreceptor Utilization. J Biol Chem. 2001;276: 13433\u201313441. 10.1074/jbc.M009779200", "ArticleIdList": ["10.1074/jbc.M009779200", "11278567"]}, {"Citation": "Clevestig P, Pramanik L, Leitner T, Ehrnst A. CCR5 use by human immunodeficiency virus type 1 is associated closely with the gp120 V3 loop N-linked glycosylation site. J Gen Virol. 2006;87: 607\u2013612. 10.1099/vir.0.81510-0", "ArticleIdList": ["10.1099/vir.0.81510-0", "16476981"]}, {"Citation": "Frost SDW, Liu Y, Pond SLK, Chappey C, Wrin T, Petropoulos CJ, et al. Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Envelope Variation and Neutralizing Antibody Responses during Transmission of HIV-1 Subtype B. 2005;79: 6523\u20136527. 10.1128/JVI.79.10.6523-6527.2005", "ArticleIdList": ["10.1128/JVI.79.10.6523-6527.2005", "PMC1091710", "15858036"]}, {"Citation": "Salazar-Gonzalez JF, Salazar MG, Keele BF, Learn GH, Giorgi EE, Li H, et al. Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection. J Exp Med. 2009;206: 1273\u201389. 10.1084/jem.20090378", "ArticleIdList": ["10.1084/jem.20090378", "PMC2715054", "19487424"]}, {"Citation": "Keele BF. Identifying and characterizing recently transmitted viruses. Curr Opin HIV AIDS. 2010;5: 327\u201334. 10.1097/COH.0b013e32833a0b9b", "ArticleIdList": ["10.1097/COH.0b013e32833a0b9b", "PMC2914479", "20543609"]}, {"Citation": "Gnanakaran S, Bhattacharya T, Daniels M, Keele BF, Hraber PT, Lapedes AS, et al. Recurrent signature patterns in hiv-1 b clade envelope glycoproteins associated with either early or chronic infections. PLoS Pathog. 2011;7: e1002209 10.1371/journal.ppat.1002209", "ArticleIdList": ["10.1371/journal.ppat.1002209", "PMC3182927", "21980282"]}, {"Citation": "Piguet V, Steinman RM. The interaction of HIV with dendritic cells: outcomes and pathways. Trends Immunol. 2007;28: 503\u2013510. 10.1016/j.it.2007.07.010", "ArticleIdList": ["10.1016/j.it.2007.07.010", "PMC7106400", "17950666"]}, {"Citation": "Turville SG, Santos JJ, Frank I, Cameron PU, Wilkinson J, Miranda-Saksena M, et al. Immunodeficiency virus uptake, turnover, and 2-phase transfer in human dendritic cells. Blood. 2004;103: 2170\u20132179. 10.1182/blood-2003-09-3129", "ArticleIdList": ["10.1182/blood-2003-09-3129", "14630806"]}, {"Citation": "Wilen CB, Parrish NF, Pfaff JM, Decker JM, Henning EA, Haim H, et al. Phenotypic and immunologic comparison of clade B transmitted/founder and chronic HIV-1 envelope glycoproteins. J Virol. 2011;85: 8514\u201327. 10.1128/JVI.00736-11", "ArticleIdList": ["10.1128/JVI.00736-11", "PMC3165820", "21715507"]}, {"Citation": "Brooks DG, Trifilo MJ, Edelmann KH, Teyton L, McGavern DB, Oldstone MBA. Interleukin-10 determines viral clearance or persistence in vivo. Nat Med. 2006;12: 1301\u20139. 10.1038/nm1492", "ArticleIdList": ["10.1038/nm1492", "PMC2535582", "17041596"]}, {"Citation": "Ejrnaes M, Filippi CM, Martinic MM, Ling EM, Togher LM, Crotty S, et al. Resolution of a chronic viral infection after interleukin-10 receptor blockade. J Exp Med. 2006;203: 2461\u201372. 10.1084/jem.20061462", "ArticleIdList": ["10.1084/jem.20061462", "PMC2118120", "17030951"]}, {"Citation": "Wilson EB, Brooks DG. The role of IL-10 in regulating immunity to persistent viral infections. Curr Top Microbiol Immunol. 2011;350: 39\u201365. 10.1007/82_2010_96", "ArticleIdList": ["10.1007/82_2010_96", "PMC3492216", "20703965"]}, {"Citation": "van Kooyk Y, Geijtenbeek TBH. DC-sign: Escape mechanism for pathogens. Nat Rev Immunol. 2003;3: 697\u2013709. 10.1038/nri1182", "ArticleIdList": ["10.1038/nri1182", "12949494"]}, {"Citation": "Geijtenbeek TBH, Gringhuis SI. Signalling through C-type lectin receptors: shaping immune responses. Nat Rev Immunol. Nature Publishing Group; 2009;9: 465\u201379. 10.1038/nri2569", "ArticleIdList": ["10.1038/nri2569", "PMC7097056", "19521399"]}, {"Citation": "Geijtenbeek TBH, van Vliet SJ, Koppel EA, Sanchez-Hernandez M, Vandenbroucke-Grauls C, Appelmelk B, et al. Mycobacteria target DC-SIGN to suppress dendritic cell function. J Exp Med. 2003;197: 7\u201317. 10.1084/jem.20021229", "ArticleIdList": ["10.1084/jem.20021229", "PMC2193797", "12515809"]}, {"Citation": "Gringhuis SI, den Dunnen J, Litjens M, van der Vlist M, H Geijtenbeek TB. Carbohydrate-specific signaling through the DC-SIGN signalosome tailors immunity to Mycobacterium tuberculosis, HIV-1 and Helicobacter pylori. Nat Immunol. 2009;10: 0\u20138. 10.1038/ni.1778", "ArticleIdList": ["10.1038/ni.1778", "19718030"]}, {"Citation": "Roberts L, Passmore JAS, Mlisana K, Williamson C, Little F, Bebell LM, et al. Genital tract inflammation during early HIV-1 infection predicts higher plasma viral load set point in women. J Infect Dis. 2012;205: 194\u2013203. 10.1093/infdis/jir715", "ArticleIdList": ["10.1093/infdis/jir715", "PMC3244362", "22190580"]}, {"Citation": "Bebell LM, Passmore J, Williamson C, Mlisana K, Iriogbe I, Loggerenberg F Van, et al. Relationship between Levels of Inflammatory Cytokines in the Genital Tract and CD4+ Cell Counts in Women with Acute HIV-1 Infection. J Infect Dis. 2008;198: 710\u2013714. 10.1086/590503", "ArticleIdList": ["10.1086/590503", "18643751"]}, {"Citation": "Masson L, Mlisana K, Little F, Werner L, Mkhize NN, Ronacher K, et al. Defining genital tract cytokine signatures of sexually transmitted infections and bacterial vaginosis in women at high risk of HIV infection: a cross-sectional study. Sex Transm Infect. 2014; 1\u20138. 10.1136/sextrans-2014-051601", "ArticleIdList": ["10.1136/sextrans-2014-051601", "25107710"]}, {"Citation": "Haase AT. Targeting early infection to prevent HIV-1 mucosal transmission. Nature. Nature Publishing Group; 2010;464: 217\u2013223. 10.1038/nature08757", "ArticleIdList": ["10.1038/nature08757", "20220840"]}, {"Citation": "Hladik F, Doncel GF. Preventing mucosal HIV transmission with topical microbicides: challenges and opportunities. Antiviral Res. Elsevier B.V.; 2010;88 Suppl 1: S3\u20139. 10.1016/j.antiviral.2010.09.011", "ArticleIdList": ["10.1016/j.antiviral.2010.09.011", "PMC3032991", "21109065"]}, {"Citation": "Hladik F, Hope TJ. HIV infection of the genital mucosa in women. Curr HIV/AIDS Rep. 2009;6: 20\u20138. Available: http://www.ncbi.nlm.nih.gov/pubmed/19149993\n10.1007/s11904-009-0004-1\n", "ArticleIdList": ["10.1007/s11904-009-0004-1", "19149993"]}, {"Citation": "Masson L, Passmore J-AS, Liebenberg LJ, Werner L, Baxter C, Arnold KB, et al. Genital Inflammation and the Risk of HIV Acquisition in Women. Clin Infect Dis. 2015;61: 260\u2013269. 10.1093/cid/civ298", "ArticleIdList": ["10.1093/cid/civ298", "PMC4565995", "25900168"]}, {"Citation": "Van Kooyk Y, Engering A, Lekkerkerker AN, Ludwig IS, Geijtenbeek TBH. Pathogens use carbohydrates to escape immunity induced by dendritic cells. Current Opinion in Immunology. 2004. pp. 488\u2013493. 10.1016/j.coi.2004.05.010", "ArticleIdList": ["10.1016/j.coi.2004.05.010", "15245744"]}, {"Citation": "Den Dunnen J, Gringhuis SI, Geijtenbeek TBH. Innate signaling by the C-type lectin DC-SIGN dictates immune responses. Cancer Immunol Immunother. 2009;58: 1149\u20131157. 10.1007/s00262-008-0615-1", "ArticleIdList": ["10.1007/s00262-008-0615-1", "PMC11030075", "18998127"]}]}], "History": [{"Year": "2019", "Month": "7", "Day": "23"}, {"Year": "2019", "Month": "12", "Day": "20"}, {"Year": "2020", "Month": "1", "Day": "25", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "1", "Day": "25", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "4", "Day": "11", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "1", "Day": "24"}], "PublicationStatus": "epublish", "ArticleIdList": ["31978062", "PMC6980567", "10.1371/journal.pone.0227533", "PONE-D-19-18332"]}}]}